Teva Pharmaceutical Industries Ltd Gets FDA Green Signal For Its Acute Asthma … – Bidness ETC


Bidness ETC

Teva Pharmaceutical Industries Ltd Gets FDA Green Signal For Its Acute Asthma
Bidness ETC
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA), the world's largest seller of generic drugs based in Israel, has yet another victory to add to its success story. Its acute asthma inhaler has finally pocketed the approval from the US Food and
First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma ApprovedMonthly Prescribing Reference
FDA approves ProAir RespiClick for treatment of acute asthma symptomsHealio
FDA clears Teva asthma med (TEVA)Seeking Alpha (registration)
Arutz Sheva –Medscape
all 17 news articles »

View full post on asthma – Google News

GSK’s Asthma Treatment Gets FDA Approval – Bidness Etc


Bidness Etc

GSK's Asthma Treatment Gets FDA Approval
Bidness Etc
Yesterday, GlaxoSmithKline plc (GSK) announced that the Food and Drug Administration (FDA) has given marketing approval for its drug Arnuity Ellipta, developed as an asthma treatment in patients aged 12 and older. Asthma is a lingering lung disease
FDA OKs New Maintenance Asthma Treatment Arnuity ElliptaMedscape
FDA approves GSK asthma medicinePhiladelphia Business Journal (blog)
FDA approves GSK's Arnuity Ellipta for treating asthmaHealio
Monthly Prescribing Reference –News-Medical.net –The Pharma Letter
all 21 news articles »

View full post on asthma – Google News